Biotechnology in Spain

Introduction

Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.

*The Spanish biotechnology market had total revenue of $18,378.3 million in 2010, representing a compound annual growth rate (CAGR) of 24.8% between 2006 and 2010.

*Medical/Healthcare sales proved the most lucrative for the Spanish biotechnology market in 2010, with total revenues of $14,076.1 million, equivalent to 76.6% of the market's overall value.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 7.8% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $26,702.1 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Spain

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Spain

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Spain biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Spain economy

Key Questions Answered

What was the size of the Spain biotechnology market by value in 2010?

What will be the size of the Spain biotechnology market in 2015?

What factors are affecting the strength of competition in the Spain biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Spain's biotechnology market?
[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
LEADING COMPANIES 19
Astra Zeneca 19
Esteve Group 23
Grifols 25
Zeltia 28
MARKET FORECASTS 29
Market value forecast 29
MACROECONOMIC INDICATORS 30
APPENDIX 32
Methodology 32
Industry associations 33
Related Datamonitor research 33
Disclaimer 34
ABOUT DATAMONITOR 35
Premium Reports 35
Summary Reports 35
Datamonitor consulting 35

LIST OF TABLES
Table 1: Spain biotechnology market value: $ million, 2006–10 10
Table 2: Spain biotechnology market segmentation I:% share, by value, 2010 11
Table 3: Spain biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Astra Zeneca: key facts 19
Table 5: Astra Zeneca: key financials ($) 21
Table 6: Astra Zeneca: key financial ratios 21
Table 7: Esteve Group: key facts 23
Table 8: Grifols: key facts 25
Table 9: Grifols: key financials ($) 26
Table 10: Grifols: key financials (€) 26
Table 11: Grifols: key financial ratios 26
Table 12: Zeltia: key facts 28
Table 13: Spain biotechnology market value forecast: $ million, 2010–15 29
Table 14: Spain size of population (million), 2006–10 30
Table 15: Spain gdp (constant 2000 prices, $ billion), 2006–10 30
Table 16: Spain gdp (current prices, $ billion), 2006–10 30
Table 17: Spain inflation, 2006–10 31
Table 18: Spain consumer price index (absolute), 2006–10 31
Table 19: Spain exchange rate, 2006–10 31

LIST OF FIGURES
Figure 1: Spain biotechnology market value: $ million, 2006–10 10
Figure 2: Spain biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: Spain biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in Spain, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in Spain, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in Spain, 2010 15
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2010 16
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2010 17
Figure 9: Drivers of degree of rivalry in the biotechnology market in Spain, 2010 18
Figure 10: Astra Zeneca: revenues & profitability 22
Figure 11: Astra Zeneca: assets & liabilities 22
Figure 12: Grifols: revenues & profitability 27
Figure 13: Spain biotechnology market value forecast: $ million, 2010–15 29


[Inhaltsverzeichnis ausblenden]